Skip to main content
KROS logo

KROS · Keros Therapeutics, Inc. · Debt

Track KROS — free
$11.31 +0.14 (+1.25%) At close · Sep 9
Market Cap
$224.44M
Shares
19.83M

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.
Key facts CIK 1664710 CUSIP 492327101 13F (30d) 94 filings 94 filers Visit website Investor relations